To study whether there is agreement between cardiovascular drugs presented at patient interview and pharmacy records in an elderly population. Setting The Rotterdam Elderly Study, a prospective population based cohort study of people older than 55 years of age. Methods We compared cardiovascular drug use as presented during patient interview with the computerized pharmacy medication history. Concordance of cardiovascular drug use in patient interview and pharmacy data was measured by merging the two data sets and assessed in two episodes: in a period of 6 months before patient interview and within the legend duration of each cardiovascular drug. Results We found 2706 concordant pairs in a total of 3365 prescriptions (80.4%) in the merged data. There were 195 prescriptions presented at patient interview which had not been filled at the pharmacy, and 464 which had been filled but were not presented by the patient. The percentage of concordant pairs slightly increased to 80.6% (2275 of a total of 2824) for prescriptions of which the legend duration included the date of patient interview. The highest agreement was noted with b-adrenoceptor blocking agents with Kappa statistics of 0.97 for atenolol and metoprolol. The lowest Kappa statistic was found for organo-heparinoid, mainly as ointments against haemorrhoids (0.26). Conclusion The agreement between patient interview and pharmacy records is good for prescription only drugs, and pharmacy records are a useful resource for pharmacoepidemiological studies on cardiovascular agents.
Introduction medication history, and from patient interview. Pharmacy records are usually considered as more complete resources An exponential growth in the number of drugs available for treatment and prevention of disability and disease has for drug exposure than medical records, and they are often used to assess the completeness of medical records [5] [6] [7] [8] [9] [10] [11] . occurred over the last 50 years [1] . A large number of relatively safe and effective drugs has been introduced into Little attention, however, has been paid to the nature of available information or accuracy of prescription databases the medical market [2] . Since the usage of drugs has been rising, it is important to study their effects in large used for pharmacoepidemiological research [1, 2] . The validity of drug exposure information is a concern populations, i.e. pharmacoepidemiological research [3] . General contributions of pharmacoepidemiology are to solve in epidemiological studies of drug-disease relationships as even slight random misclassification of exposure may lead issues on drug safety and to quantify drug effects and risk factors. Pharmacoepidemiology is important to get inforto non-valid risk estimations [11, 12] . Validity is often characterized by the degree of agreement between data mation that supplements that available from premarketing studies, to get better quantification of known adverse and collected by interview and prescribed therapies as documented in the medical record [5] . Although the beneficial effects and to provide data for pharmacoeconomics and drug utilization [3] . Rising drug costs and fiscal literature uses the term 'validity' to describe the agreement between two sources of information, 'agreement' or constraints in health care budgets have inspired a growing interest in pharmacoepidemiology, especially in elderly 'concordance' is a more appropriate term to describe the comparison between drugs exposures provided by interview subjects with their risk factors for adverse reactions such as polypharmacy, deterioration in homeostatic mechanisms and and medical records or pharmacy data, because even patient interview data are not a true gold standard for drug altered pharmacokinetics and pharmacodynamics [4] .
In pharmacoepidemiology, the accuracy of exposure exposure, i.e. compliance. A previous study revealed that the overall proportion of concordance for estrogen use assessment is important. Data on drug use may be obtained between patient interview and the medical record is 75% the sensitivity of pharmacy data as a proxy of drug reference. Firstly, for each patient we assessed the concordance of interview data with the pharmacy data in a presentation at interview varied from 50% to 91% [9] .
In this report, we assessed the agreement between patient 6 months period before the date of the interview. Secondly, we then compared all prescriptions for which the interview interview and the pharmacy record by studying whether filling data from the pharmacy were compatible with the date fell within the legend duration. This legend duration was defined as the period between the date of prescribing drugs shown during the patient interview. Also, we studied whether this agreement varied with age, gender, and and the anticipated end date which was calculated by dividing the amount of drug units given to the patients by educational or socio-economic status. Cardiovascular drug prescriptions were used in this study because they are the prescribed daily dose per patient. In the results, we distinguished between two categories: concordant and frequently prescribed in elderly people [4] , and because they are used on a chronic basis that facilitates a relevant and discordant pairs. Concordant pairs are prescriptions of which the ATC code coincided in both ERGO and pharmacy data more reliable comparison.
on a seven digits level, and pairs were discordant when this was not the case. The concordance between patient Methods interview and pharmacy records was also assessed for the five first digits of the ATC code.
Setting
We were also interested in the description of the discordant pairs, how many prescriptions were presented during patient The Rotterdam Elderly Study (ERGO) study is a population based study of people 55 years of age and older living in interview but not in pharmacy data and vice versa. For that reason we calculated the frequency of each ATC code in both the district Ommoord, Rotterdam, the Netherlands. This prospective cohort study was designed to investigate patient interview and pharmacy data and identified the distinction between patient interview's ATC code and phardeterminants of the occurrence and progression of chronic diseases in the elderly. The rationale and design of this study macy ATC code. Besides overall concordance, kappa statistics were used to assess the agreement for the eleven most have been described elsewhere [14] . The cohort encompasses 7983 individuals. The large majority of patients fill their commonly notified drugs in both databases [15] . Univariate analysis using SPSS was performed for a description of patient drugs at one large pharmacy that is fully computerized. Interview in this study was done by trained interviewers characteristics (gender, age, education and income). who also notified which drug canisters were presented by the patients to the question on current drug use.
Results To assess the agreement between patient interview and pharmacy data, we used the prescription database for Most of the 1682 patients in this study were female (64%). The highest number of patients was in the age group 65-74 cardiovascular drugs obtained from patient interview in the Rotterdam Elderly Study during the interview period years (36.3%). Education of the patients varied from primary school (40.9%), secondary school (46.7%), to college or between 1st June 1991 and 1st June 1993, and data from the pharmacy within 6 months before patient interview. university (9.2%). Income per month varied from below Dfl.1000 (23.5%) to more than Dfl.5.000 (2.1%) (Table 1) . Atenolol, hydrochlorothiazide and K + -sparing diuretics, Exposure data digoxin, frusemide and metoprolol were among the five most commonly notified drugs in both pharmacy and patient The Rotterdam Elderly Study provided an ERGO identification number, Anatomical Therapeutical Chemical (ATC) interview data (Table 2) . After merging of the two databases, there were 3365 code for each drug presented at interview, date of interview, and patient characteristics such as age and education. The prescriptions of which there were 2706 concordant pairs (80.4%) and 659 discordant pairs (19.6%). If we only pharmacy data included the ERGO identification number, ATC code, date of prescribing, the amount of drug units compare the prescriptions of which the interview date fell within the legend duration, the concordance percentage did given to patients, drug units taken by patients per day, daily dosages and other variables such as age and gender of the not change much (80.6%). When restricted to the first five digits of the ATC code, the percentage of concordance patient, and generic name of the drugs. Records with missing ATC-codes were excluded. The ATC-code for between patient interview and pharmacy records further increased to 81.4% (Figure 1 ). cardiovascular drugs consists of seven digits and is divided into eight groups, C01 (cardiac drugs), C02 (antihypertensive Regarding the discordant pairs, there were 464 drugs that were filled at the pharmacy but which were not presented agents), C03 (diuretics), C04 ( peripheral vasodilators), C05 (vasoprotective agents), C07 (beta blocking agents), C08 during patient interview and 195 drugs presented during patient interview which were not filled at the pharmacy. (selective calcium antagonists with direct heart effect) and C09 (angiotensin converting enzyme (ACE)-inhibitors).
When restricted to prescriptions in which the interview date fell within the legend duration, there were 154 drugs presented by the pharmacy but not during patient interview Procedure and 395 drugs vice versa (Table 3) . Hence, the overall sensitivity of pharmacy data taking the patient interview as The two databases were merged according to the ERGO identification number. Overall concordance between patient a gold standard was 93.3% for all prescriptions and 85.2% when restricted to the legend duration. Of all pharmacy interview and pharmacy records was calculated using the total number of prescriptions from both databases as a prescriptions 85.4% were presented at interview date and duration respectively (Table 6 ). There were no significant 9 Nifedipine 130 (3.9) differences in the level of agreement for age, gender, and 10 Epitizide+K + -sparing diuretic 117 (3.5) educational or socio-economic status.
93.7% of prescriptions in the legend duration period were Discussion presented at the patient interview. Table 4 shows that b-adrenoceptor blocking agents had In pharmacoepidemiology, drug exposure assessment depends on adequate registration of drug dispensing and on the highest percentage of concordant pairs among cardiovascular drug groups in prescriptions within the legend duration compliance by the patient [16] . Both items are important as even slight misclassification may have consequences for (98.3%) whereas vasoprotective drugs had the lowest (35.3%). For all prescriptions, these percentages were 93.9 relative risk assessments [11, 12] . Although it is clear from this study that pharmacy filling data show a high agreement and 23.1 respectively. For all prescriptions, the highest with the drugs presented by the patient, the latter does not not able to calculate the specificity as the number of prescriptions not filled at the pharmacy and not presented at prove that a patient is compliant. Even so, our figures are quite reassuring and in line with a similar study in a much patient interview is meaningless and cannot be assessed. Management of pharmacotherapy by the pharmacist and the smaller population [9] . At variance with that study, we were general practitioner can be a difficult task in elderly patients records are a useful resource for pharmacoepidemiological studies. in whom chronic drug use is common, and self-reported drug use in elderly is not necessarily a gold standard [17] . There are still 154 prescriptions from the pharmacy record References (in the legend duration) that were not presented at patient interview. There may be three reasons. Firstly, the prescrip- 
